0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Research, Methods, Statistics
 281-300 of 494 Articles
Editorial | 
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD
JAMA. 2012;307(8):849-850. doi:10.1001/jama.2012.195.

Health Agencies Update | 
Bridget M. Kuehn
JAMA. 2012;307(8):773. doi:10.1001/jama.2012.174.

Editorial |  FREE
Drummond Rennie, MD; Annette Flanagin, RN, MA; Fiona Godlee, MBBChir, MRCP; et al.
JAMA. 2012;307(7):726-727. doi:10.1001/jama.2012.150.

Lab, Field, and Clinic | 
Bridget M. Kuehn
JAMA. 2012;307(7):655. doi:10.1001/jama.2012.131.

Viewpoint | 
Travis T. Tollefson, MD, MPH; Wayne F. Larrabee, MD
JAMA. 2012;307(7):667-668. doi:10.1001/jama.2012.158.

Medical News and Perspectives | 
Bridget M. Kuehn
JAMA. 2012;307(7):651-653. doi:10.1001/jama.2012.127.

Medical News and Perspectives | 
Rebecca Voelker
JAMA. 2012;307(6):549-550. doi:10.1001/jama.2012.83.

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2012;307(4):348-350. doi:10.1001/jama.2012.30.

Viewpoint | 
Vinay Prasad, MD; Adam Cifu, MD; John P. A. Ioannidis, MD, DSc
JAMA. 2012;307(1):37-38. doi:10.1001/jama.2011.1960.

Commentary | 
Laura J. Esserman, MD, MBA; Janet Woodcock, MD
JAMA. 2011;306(23):2608-2609. doi:10.1001/jama.2011.1837.

Commentary | 
Howard Brody, MD, PhD; Franklin G. Miller, PhD
JAMA. 2011;306(23):2612-2613. doi:10.1001/jama.2011.1850.

Commentary | 
Rashida Dorsey, PhD, MPH; Garth Graham, MD, MPH
JAMA. 2011;306(21):2378-2379. doi:10.1001/jama.2011.1789.

Commentary | 
Michael S. Lauer, MD
JAMA. 2011;306(19):2145-2146. doi:10.1001/jama.2011.1669.

Commentary | 
Franklin G. Miller, PhD; Steven D. Pearson, MD, MSc
JAMA. 2011;306(18):2024-2025. doi:10.1001/jama.2011.1631.

Commentary | 
Louis D. Fiore, MD, MPH; Leonard William D’Avolio, PhD
JAMA. 2011;306(17):1914-1915. doi:10.1001/jama.2011.1605.

Commentary | 
Jeffrey L. Probstfield, MD; Robert L. Frye, MD
JAMA. 2011;306(16):1798-1799. doi:10.1001/jama.2011.1544.

Commentary | 
Harlan M. Krumholz, MD, SM; Joseph S. Ross, MD, MHS
JAMA. 2011;306(14):1593-1594. doi:10.1001/jama.2011.1459.
Includes: Supplemental Content

The World in Medicine | 
M. J. Friedrich
JAMA. 2011;306(7):694. doi:10.1001/jama.2011.1154.

Commentary | 
Peter J. Pronovost, MD, PhD; Christine A. Goeschel, MPA, MPS, ScD, RN
JAMA. 2011;306(3):310-311. doi:10.1001/jama.2011.1015.

Editorial | 
Howard Bauchner, MD
JAMA. 2011;306(1):98-99. doi:10.1001/jama.2011.936.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Pediatrics
Editorial  | 
Evaluation of Adults Born With an Oral Cleft Aren’t Adults Just Big Kids?
Carrie L. Heike, MD, MS; Kelly N. Evans, MD
JAMA Oncology
Original Investigation  | 
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma Analysis of REACH Trial Results by Child-Pugh Score
Andrew X. Zhu, MD, PhD; Ari David Baron, MD; Peter Malfertheiner, MD; et al.
JAMA Oncology
Cancer Care Chronicles  | 
When “Actionable” Genomic Sequencing Results Cannot be Acted Upon
Brian J. Zikmund-Fisher, PhD
JAMA Oncology
Viewpoint  | 
Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials
Thomas M. Atkinson, PhD; Jan-Samuel Wagner, MPH; Ethan Basch, MD, MSc